Literature DB >> 803305

Reduced cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in children with epilepsy.

B A Shaywitz, D J Cohen, M B Bowers.   

Abstract

Cerebrospinal fluid (CSF) concentrations of 5-hydroxyindoleacetic acid (5-HIAA), homovanillic acid (HVA) and probenecid were examined in 14 children with epilepsy (ages 6 months to 17 years) and 17 controls (ages 14 months to 16 years). The concentrations of amine metabolites were significantly correlated with probenecid concentrations in both groups of children. Cerebrospinal fluid concentrations of 5-HIAA were 63.6 ng per milliliter plus or minus 8.23 S.E.M. and 117 ng per milliliter plus or minus 11.6 S.E.M. for the epilepsy and control groups respectively. HVA averaged 89.1 ng per milliliter plus or minus 15.2 S.E.M in epilepsy and 172 ng per milliliter plus or minus 19.2 S.E.M. in the control group. These findings indicate a significant difference between epilepsy and control groups. Probenecid concentrations were similar in each group. The reduced cerebrospinal fluid amine metabolite concentrations in children with epilepsy were not related to age, anticonvulsant medication, cerebrospinal fluid folate or protein concentration, or cerebrospinal fluid cell count. Our findings suggest a relationship between brain amines and epilepsy.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 803305     DOI: 10.1212/wnl.25.1.72

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

Review 1.  Clinical features, pathogenesis and management of drug-induced seizures.

Authors:  G Zaccara; G C Muscas; A Messori
Journal:  Drug Saf       Date:  1990 Mar-Apr       Impact factor: 5.606

2.  A patient with infantile spasms and low homovanillic acid levels in cerebrospinal fluid: L-dopa dependent seizures?

Authors:  H Sugie; Y Sugie; N Kato; Y Fukuyama
Journal:  Eur J Pediatr       Date:  1989-06       Impact factor: 3.183

3.  Brain 5-hydroxytryptamine level, metabolism, and binding in E1 mice.

Authors:  M Hiramatsu
Journal:  Neurochem Res       Date:  1983-09       Impact factor: 3.996

4.  Catecholamine level in cerebrospinal fluid of epileptics.

Authors:  M Hiramatsu; N Fujimoto; A Mori
Journal:  Neurochem Res       Date:  1982-10       Impact factor: 3.996

5.  Tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human cerebrospinal fluid: interrelationships and the influence of age, sex, epilepsy and anticonvulsant drugs.

Authors:  S N Young; S Gauthier; G M Anderson; W C Purdy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-05       Impact factor: 10.154

Review 6.  Abnormalities of biogenic amine metabolism.

Authors:  K Hyland
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

7.  Serotonin metabolism with idiopathic grand mal seizures.

Authors:  D R Matz; L H Rolf; G G Brune
Journal:  J Neurol       Date:  1978-12-22       Impact factor: 4.849

8.  Homovanilic acid in Huntington's disease and Sydenham's chorea.

Authors:  L Cunha; C R Oliveira; M Diniz; R Amaral; A F Conçalves; J Pio-Abreu
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-03       Impact factor: 10.154

Review 9.  Analysis of Catecholamines and Pterins in Inborn Errors of Monoamine Neurotransmitter Metabolism-From Past to Future.

Authors:  Sabine Jung-Klawitter; Oya Kuseyri Hübschmann
Journal:  Cells       Date:  2019-08-09       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.